Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.
Visonà
Adriana
A
Unità di Angiologia, Ospedale San Giacomo, Castelfranco Veneto (TV), Italy. adriana.visona@ulssasolo.ven.it
Tonello
Diego
D
Zalunardo
Beniamino
B
Irsara
Sandro
S
Liessi
Guido
G
Marigo
Lucia
L
Zotta
Laura
L
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary / Q000534:rehabilitation; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D023903:Coronary Restenosis / Q000517:prevention & control*; D004176:Dipyridamole / Q000627:therapeutic use; D004338:Drug Combinations; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy
D000911:Antibodies, Monoclonal; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines; C446540:thienopyridine; D004176:Dipyridamole; D001241:Aspirin; D000077284:Abciximab